8 results on '"fluorescence cytometry"'
Search Results
2. Evidence of metabolically active but non-culturable Listeria monocytogenes in long-term growth at 10 °C.
- Author
-
Gurresch, Anna, Gerner, Wilhelm, Pin, Carmen, Wagner, Martin, and Hein, Ingeborg
- Subjects
- *
LISTERIA monocytogenes , *TEMPERATURE effect , *BIOTRANSFORMATION (Metabolism) , *REDUCTASE genetics , *DIAGNOSTIC use of flow cytometry - Abstract
Cultures of Listeria monocytogenes at low temperatures (10 °C) in a broth model revealed long-term survival at about 0.04% cell density in relation to the log phase. In contrast, direct viable counts and PMA real-time PCR data suggested that 50% and 1% of the population retain membrane integrity, respectively. To elucidate the observed difference, the metabolic activity of the bacterial population was investigated by multiparametric flow cytometry, including the assessment of membrane integrity, reductase activity, as well as forward and side scatter properties. These analyses were complemented by 16S rRNA real-time PCR. The majority of the cells retained their membrane integrity and reductase activity until day 29. On day 42, 48.00 ± 4.00% ( L. monocytogenes strain 3251) and 68.67 ± 3.74% ( L. monocytogenes strain 535) of the cells had intact membranes, whereas 57.23 ± 1.85% (strain 3251) and 74.97 ± 3.01% (strain 535) exhibited high reductase activity. On day 42, mean 16S rRNA copy numbers of 3.98 ± 1.37 (membrane integrity) and 3.86 ± 1.32 (reductase activity) remained per intact or active cell. Our data suggest the transition of L. monocytogenes into a state of metabolic dormancy during long-term culture at low temperature. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
3. Multiparameter analysis of stimulated human peripheral blood mononuclear cells: A comparison of mass and fluorescence cytometry.
- Author
-
Nicholas, Katherine J., Greenplate, Allison R., Flaherty, David K., Matlock, Brittany K., Juan, Juan San, Smith, Rita M., Irish, Jonathan M., and Kalams, Spyros A.
- Abstract
Mass and fluorescence cytometry are quantitative single cell flow cytometry approaches that are powerful tools for characterizing diverse tissues and cellular systems. Here mass cytometry was directly compared with fluorescence cytometry by studying phenotypes of healthy human peripheral blood mononuclear cells (PBMC) in the context of superantigen stimulation. One mass cytometry panel and five fluorescence cytometry panels were used to measure 20 well-established lymphocyte markers of memory and activation. Comparable frequencies of both common and rare cell subpopulations were observed with fluorescence and mass cytometry using biaxial gating. The unsupervised high-dimensional analysis tool viSNE was then used to analyze data sets generated from both mass and fluorescence cytometry. viSNE analysis effectively characterized PBMC using eight features per cell and identified similar frequencies of activated CD4+ T cells with both technologies. These results suggest combinations of unsupervised analysis programs and extended multiparameter cytometry will be indispensable tools for detecting perturbations in protein expression in both health and disease. © 2015 International Society for Advancement of Cytometry [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. DNA-fluorescence-cytometry and prognosis (grading) of meningiomas - a study of 104 surgically removed tumors.
- Author
-
Spaar, Friedrich-Wilhelm, Ahyai, Alireza, and Blech, Manfred
- Abstract
A total of 104 meningiomas of various histological types were examined microscopically and with flow fluorescence cytometry using the EBR staining technique and either an ICP 11 or an ICP 22 (PHYWE). Also tissue culture cells of 72 tumors were studied for their DNA content. There was a variable DNA distribution, which allowed a grading of malignancy according to a 3 or 4 grade scale. Useful information on the nature of a meningioma and its proliferative activity can be obtained during the surgical treatment. A majority of meningiomas show slowly proliferative DNA patterns typical for benign tumors. More than one third of the meningiomas show an intermediate configuration, probably associated with more or less semi-benign proliferative activity. 5.8% of our cases showed primary malignant tumors - except meningosarcomas. [ABSTRACT FROM AUTHOR]
- Published
- 1987
- Full Text
- View/download PDF
5. Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indications
- Author
-
Morado, Morado, Sandes, Alex F., Colado, Enrique, Subirá, Dolores, Isusi, Paloma, Noya, María Soledad, Vidriales, Maria Belén, Sempere, Amparo, Díaz, José Ángel, Minguela, Alfredo, Álvarez, Beatriz, Serrano, Cristina, Caballero-Velázquez, Teresa, Rey, Mercedes, Pérez Corral, Ana, Fernández Jiménez, María Crsitina, Magro, Elena, Lemes, Angelina, Benavente, Cecilia, Bañas, Helena, Merino, Juana, Castejon, Celine, Gutierrez, Olivier, Rabasa, Pilar, Vescovi Gonçalves, Matheus, Pérez-Andrés, Martin, Orfao, Alberto, Morado, Morado, Sandes, Alex F., Colado, Enrique, Subirá, Dolores, Isusi, Paloma, Noya, María Soledad, Vidriales, Maria Belén, Sempere, Amparo, Díaz, José Ángel, Minguela, Alfredo, Álvarez, Beatriz, Serrano, Cristina, Caballero-Velázquez, Teresa, Rey, Mercedes, Pérez Corral, Ana, Fernández Jiménez, María Crsitina, Magro, Elena, Lemes, Angelina, Benavente, Cecilia, Bañas, Helena, Merino, Juana, Castejon, Celine, Gutierrez, Olivier, Rabasa, Pilar, Vescovi Gonçalves, Matheus, Pérez-Andrés, Martin, and Orfao, Alberto
- Abstract
[Background]: Although consensus guidelines have been proposed in 2010 for the diagnostic screening of paroxysmal nocturnal hemoglobinuria (PNH) by flow cytometry (FCM), so far no study has investigated the efficiency of such medical indications in multicentric vs. reference laboratory settings. [Methods]: Here we evaluate the efficiency of consensus medical indications for PNH testing in 3,938 peripheral blood samples submitted to FCM testing in 24 laboratories in Spain and one reference center in Brazil. [Results]: Overall, diagnostic screening based on consensus medical indications was highly efficient (14% of PNH samples) both in the multicenter setting in Spain (10%) and the reference laboratory in Brazil (16%). The highest frequency of PNH cases was observed among patients screened because of bone marrow (BM) failure syndrome (33%), particularly among those with aplastic anemia (AA; 45%) and to a less extent also a myelodysplastic syndrome (MDS; 10%). Among the other individuals studied, the most efficient medical indications for PNH screening included: hemolytic anemia (19%), hemoglobinuria (48%) and unexplained cytopenias (9%). In contrast, only a minor fraction of the patients who had been submitted for PNH testing because of unexplained thrombosis in the absence of cytopenia, were positive (0.4%). [Conclusions]: In summary, our results demonstrate that the current medical indications for PNH screening by FCM are highly efficient, although improved screening algorithms are needed for patients presenting with thrombosis and normal blood cell counts.
- Published
- 2017
6. Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indications
- Author
-
Morado, M, Freire Sandes, A, Colado, E, Subira, D, Isusi, P, Soledad Noya M, Belén Vidriales M, Sempere, A, Ángel Díaz J, Minguela, A, Alvarez, B, Serrano, C, Caballero, T, Rey, M, Pérez Corral A, Cristina Fernández Jiménez M, Magro, E, Lemes, A, Benavente, C, Bañas H, Merino, J, Castejon, C, Gutierrez, O, Rabasa, P, Vescosi Gonçalves M, Perez-Andres, M, Orfao, A, and PNH working group of the Iberian Society of Cytometry (SIC)
- Subjects
standardization ,Male ,Erythrocytes ,hematology ,flow cytometry ,Hemoglobinuria, Paroxysmal ,Anemia, Aplastic ,myelodysplastic syndrome ,hemic and lymphatic diseases ,Myelodysplastic Syndromes ,Prevalence ,Humans ,Female ,fluorescence cytometry ,Prospective Studies ,Retrospective Studies - Abstract
BackgroundAlthough consensus guidelines have been proposed in 2010 for the diagnostic screening of paroxysmal nocturnal hemoglobinuria (PNH) by flow cytometry (FCM), so far no study has investigated the efficiency of such medical indications in multicentric vs. reference laboratory settings. MethodsHere we evaluate the efficiency of consensus medical indications for PNH testing in 3,938 peripheral blood samples submitted to FCM testing in 24 laboratories in Spain and one reference center in Brazil. ResultsOverall, diagnostic screening based on consensus medical indications was highly efficient (14% of PNH+ samples) both in the multicenter setting in Spain (10%) and the reference laboratory in Brazil (16%). The highest frequency of PNH+ cases was observed among patients screened because of bone marrow (BM) failure syndrome (33%), particularly among those with aplastic anemia (AA; 45%) and to a less extent also a myelodysplastic syndrome (MDS; 10%). Among the other individuals studied, the most efficient medical indications for PNH screening included: hemolytic anemia (19%), hemoglobinuria (48%) and unexplained cytopenias (9%). In contrast, only a minor fraction of the patients who had been submitted for PNH testing because of unexplained thrombosis in the absence of cytopenia, were positive (0.4%). ConclusionsIn summary, our results demonstrate that the current medical indications for PNH screening by FCM are highly efficient, although improved screening algorithms are needed for patients presenting with thrombosis and normal blood cell counts. (c) 2016 International Clinical Cytometry Society
- Published
- 2016
7. Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indications.
- Author
-
Morado M, Freire Sandes A, Colado E, Subirá D, Isusi P, Soledad Noya M, Belén Vidriales M, Sempere A, Ángel Díaz J, Minguela A, Álvarez B, Serrano C, Caballero T, Rey M, Pérez Corral A, Cristina Fernández Jiménez M, Magro E, Lemes A, Benavente C, Bañas H, Merino J, Castejon C, Gutierrez O, Rabasa P, Vescosi Gonçalves M, Perez-Andres M, and Orfao A
- Subjects
- Anemia, Aplastic epidemiology, Anemia, Aplastic metabolism, Female, Flow Cytometry methods, Hemoglobinuria, Paroxysmal metabolism, Humans, Male, Myelodysplastic Syndromes epidemiology, Myelodysplastic Syndromes metabolism, Prevalence, Prospective Studies, Retrospective Studies, Anemia, Aplastic diagnosis, Erythrocytes cytology, Hemoglobinuria, Paroxysmal diagnosis, Hemoglobinuria, Paroxysmal epidemiology, Myelodysplastic Syndromes diagnosis
- Abstract
Background: Although consensus guidelines have been proposed in 2010 for the diagnostic screening of paroxysmal nocturnal hemoglobinuria (PNH) by flow cytometry (FCM), so far no study has investigated the efficiency of such medical indications in multicentric vs. reference laboratory settings., Methods: Here we evaluate the efficiency of consensus medical indications for PNH testing in 3,938 peripheral blood samples submitted to FCM testing in 24 laboratories in Spain and one reference center in Brazil., Results: Overall, diagnostic screening based on consensus medical indications was highly efficient (14% of PNH
+ samples) both in the multicenter setting in Spain (10%) and the reference laboratory in Brazil (16%). The highest frequency of PNH+ cases was observed among patients screened because of bone marrow (BM) failure syndrome (33%), particularly among those with aplastic anemia (AA; 45%) and to a less extent also a myelodysplastic syndrome (MDS; 10%). Among the other individuals studied, the most efficient medical indications for PNH screening included: hemolytic anemia (19%), hemoglobinuria (48%) and unexplained cytopenias (9%). In contrast, only a minor fraction of the patients who had been submitted for PNH testing because of unexplained thrombosis in the absence of cytopenia, were positive (0.4%)., Conclusions: In summary, our results demonstrate that the current medical indications for PNH screening by FCM are highly efficient, although improved screening algorithms are needed for patients presenting with thrombosis and normal blood cell counts. © 2016 International Clinical Cytometry Society., (© 2016 International Clinical Cytometry Society.)- Published
- 2017
- Full Text
- View/download PDF
8. Phospho-Flow Analysis of Primary Mouse Cells After HDAC Inhibitor Treatment.
- Author
-
Hildebrand D and Kubatzky KF
- Subjects
- Animals, Antibodies, Monoclonal chemistry, Bone Marrow Cells cytology, Bone Marrow Cells metabolism, Cell Separation methods, Fluorescein-5-isothiocyanate chemistry, Gene Expression, Histone Deacetylases genetics, Histone Deacetylases metabolism, Interferon-gamma pharmacology, Mice, Mice, Inbred C57BL, Phosphorylation, Primary Cell Culture, STAT1 Transcription Factor genetics, STAT1 Transcription Factor metabolism, Benzamides pharmacology, Bone Marrow Cells drug effects, Flow Cytometry methods, Histone Deacetylase Inhibitors pharmacology, Pyridines pharmacology, Staining and Labeling methods
- Abstract
Flow cytometric techniques allow fast, sensitive, and multiparametric analyses at the single cell level. This makes it possible to distinguish subsets of cells within heterogeneous samples. Moreover, flow cytometry has become a frequently used method for the evaluation of therapeutic effects. Here, we describe the analysis of the phosphorylation status of signal transducer and activator of transcription-1 (STAT-1) in primary mouse cells after treatment with histone deacetylase inhibitors (HDACi) that are currently considered anticancer agents. We provide detailed protocols for the preparation of murine bone marrow cells and the staining of HDACi-treated cells, as well as an insight into the concepts of flow cytometry analysis.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.